2024 Why is jnj down today - J&J also said it expected a steep decline in sales of its blockbuster Crohn's disease drug Stelara once it loses U.S. patent protection in late 2023. Shares were 2.4% lower at $161.71, making it ...

 
Updated April 18, 2023 9:53 pm ET. Listen. (2 min) Johnson & Johnson is spinning off its consumer-health business into a company that will house well-known brands such as Tylenol. Photo: George .... Why is jnj down today

Here’s Why. Oct. 19, 2023 at 10:09 a.m. ET by Barron's Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech businessJun 4, 2014 · Johnson & Johnson (NYSE:JNJ) has been hitting 52 week highs, seemingly every day. I would argue that the performance of the stock has been a result of some dynamic growth in both revenues and ... Johnson & Johnson. Market Cap. Today's Change. Current Price. $147.66. Price as of November 14, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley ...New York CNN Business —. Breaking up is the newest craze for ginormous global companies. Johnson & Johnson, Toshiba and GE announced plans to split into multiple entities this week. The trend ...JNJ Earnings Recap. Looking through the Q4 results, adjusted EPS at $2.35 climbed by 10.3% year-over-year, coming in $0.11 above the consensus. The full-year figure at $10.15 was also 4% higher ...Johnson & Johnson stock rises Thursday, outperforms market. Nov. 30, 2023 at 4:32 p.m. ET by MarketWatch Automation.Mar 2, 2023 · Analysts expect JNJ’s revenue to increase 2.8% year-over-year to $97.62 billion for the fiscal year ending December 2023. The company’s EPS for the ongoing year is expected to rise 3.6% from the previous year to $10.51. Moreover, JNJ surpassed its consensus EPS estimates in all four trailing quarters, which is impressive. Updated April 18, 2023 9:53 pm ET. Listen. (2 min) Johnson & Johnson is spinning off its consumer-health business into a company that will house well-known brands such as Tylenol. Photo: George ...Shares of Johnson & Johnson (JNJ 0.32%) were sinking 4.2% lower as of 11:04 a.m. ET on Monday. The decline came after a U.S. judge ruled against the …Verizon's revenue rose 4% year over year to $34.2 billion in the third quarter. That was slightly above Wall Street's estimates for revenue of $33.8 billion. However, Verizon gained only 8,000 ...Possible side effects: Pain, redness, or swelling at the site where the shot was administered, and/or tiredness, headache, muscle pain, chills, fever, or nausea throughout the rest of the body. If these side effects occur, they should go away in a few days. A few side effects are serious, but rare. These include anaphylaxis, a severe reaction ...What happened. Shares of Johnson & Johnson ( JNJ -0.20%) were moving higher today after the company got some favorable legal news. The healthcare giant reached a settlement worth $8.9 billion over ...Johnson & Johnson stock (NYSE: JNJ) is down 8% in a month, underperforming the broader markets, with the S&P 500 index up 6%.Johnson and Johnson’s stock has taken a tumble this month. Share prices are down from their peak of $180.25 on January 6, 2023. They hit a one-month low of $168.31 on January 24, 2023, and ...Johnson & Johnson (JNJ 1.68%) is one of the top healthcare companies in the world. But the company's legal problems, particularly with its talc products, weighed down its financials over the past ...seekingalpha.com - November 17 at 6:15 PM. Exxon Mobil's Second Act. seekingalpha.com - November 17 at 5:05 PM. Commonwealth Equity Services LLC Increases Stock Holdings in Exxon Mobil Co. (NYSE:XOM) marketbeat.com - November 17 at 12:57 PM. Those who invested in Exxon Mobil (NYSE:XOM) three years ago are up …18-apr, 2023 ... Johnson & Johnson on Tuesday cautioned investors over the lingering impact of inflation-driven costs this year as the healthcare ...The stock closed nearly 3% lower Tuesday. Shares are down more than 9% for the year through the close, putting the company’s market value at roughly $420 billion. J&J is now forecasting 2023 ...Johnson & Johnson (NYSE:JNJ) stock is on the move Tuesday following the release of the company’s earnings report for the third quarter of 2022.The JNJ earnings report starts with adjusted earnings per share (EPS) of $2.55. While that’s a 1.9% decrease year-over-year (YOY), it’s still better than th…Stock analysis for Johnson & Johnson (JNJ:New York) including stock price ... Get unlimited access today.Explore Offer. Subscribe now for unlimited access ...What happened. Shares of Johnson & Johnson ( JNJ -0.18%) are down more than 2% as of 3:25 p.m. EDT Thursday as potential regulation for prescription drug prices becomes clearer. Image source ...Apr 17, 2023 · Analyst’s Disclosure: I/we have a beneficial long position in the shares of JNJ, UNLYF, MMM, RHHBF, PG, MRK either through stock ownership, options, or other derivatives. I wrote this article ... Get the LIVE share price of Johnson & Johnson(JNJ) and stock performance in one place to strengthen your trading strategy in US stocks.Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. View the full Dow Jones Industrial Average (DJIA) index overview including the latest stock market news, data and trading information.Shares of Johnson & Johnson were down almost 1% Tuesday morning. Yet even though some shareholders apparently didn't like the healthcare company 's results from the third quarter, there were ...What happened. Shares of Johnson & Johnson(NYSE: JNJ) were sinking 4.2% lower as of 11:04 a.m. ET on Monday. The decline came after a U.S. judge ruled against the healthcare giant on Friday. Judge ...Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals./ Today's Market / Why Is Johnson & Johnson (JNJ) Stock Down Today? Q3 beats are being overshadowed by the company's full-year guidance By William …Nov 12, 2021 · Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded ... Jan 31, 2023 · Today, a rejection from a U.S. court for Johnson & Johnson to use bankruptcy to solve its ongoing Talc powder litigation has JNJ stock down.More From InvestorPlace Buy This $5 Stock BEFORE This ... 17-okt, 2023 ... ... down the numbers. Subscribe to Yahoo Finance: https ... Stock market news today: Stocks slide after slew of retail earnings disappoints | November ...A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Johnson & Johnson stock (NYSE: JNJ) is down 8% in a month, underperforming the broader markets, with the S&P 500 index up 6%. Subscribe to newsletters Subscribe: $29.99/yearJohnson & Johnson's current payout ratio is 44%. This means it paid out 44% of its trailing 12-month EPS as dividend. Looking at this fiscal year, JNJ expects solid earnings growth. The Zacks ...Johnson & Johnson (JNJ 2.40%) recently provided investors with details of the long-awaited split of its consumer healthcare business Kenvue (KVUE 1.22%).It will split off at least 80.1% of its ...Jun 4, 2014 · Johnson & Johnson (NYSE:JNJ) has been hitting 52 week highs, seemingly every day. I would argue that the performance of the stock has been a result of some dynamic growth in both revenues and ... Johnson & Johnson (JNJ) shares may drop by about 10% based on an analysis of the technical chart. Johnson & Johnson's stock has already struggled thus far ...The third COVID-19 vaccine authorized for use in the U.S. requires one shot instead of two, and works a slightly different way from the others. Here's what we know about its safety and effectiveness.What happened. Shares of drugmaker AbbVie ( ABBV 0.01%) are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk ...Dec 1, 2023 · Johnson & Johnson (NYSE:JNJ) pays an annual dividend of $4.76 per share and currently has a dividend yield of 3.01%. The company has been increasing its dividend for 61 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.34%. Financial Performance During Fiscal 2021. During the fourth quarter of 2021, Johnson & Johnson reported a revenue figure of almost $25 billion, which translated into an EPS of $2.13 per share. In ...Today, a rejection from a U.S. court for Johnson & Johnson to use bankruptcy to solve its ongoing Talc powder litigation has JNJ stock down.More From InvestorPlace Buy This $5 Stock BEFORE This ...A month has gone by since the last earnings report for Johnson & Johnson (JNJ). Shares have lost about 1.8% in that time frame, underperforming the S&P 500.Sep 9, 2021 · What happened. Shares of Johnson & Johnson (NYSE: JNJ) are down more than 2% as of 3:25 p.m. EDT Thursday as potential regulation for prescription drug prices becomes clearer. Image source:... Shares of healthcare-behemoth Johnson & Johnson ( JNJ 2.40%) were down by 2.46% on heavy volume as of 2:23 p.m. ET Tuesday afternoon. The company's shares are slumping today despite its...Shares of Johnson & Johnson ( JNJ -0.21%) closed down 4.15% on Friday after Bloomberg reported that the U.S. Department of Justice (DOJ) is investigating the healthcare conglomerate as to whether ...Johnson & Johnson (NYSE: JNJ) stock is climbing today. The conglomerate offered to pay $8.9 billion to resolve lawsuits related to the talc in its baby powder and other products. Roughly 60,000 ...J&J’s consumer health spinoff Kenvue begins trading at $25.53 per share. Shares of Johnson & Johnson ’s consumer-health spinoff Kenvue jumped 22% Thursday after its market debut on the New ...JNJ stock is down 10% this year and is in shouting distance of the company’s 52-week low. Analysts expect revenue of $24.7 billion and EPS of $2.62 when JNJ reports second-quarter earnings on ...18-okt, 2022 ... Johnson & Johnson (JNJ) stock is on the move Tuesday following the release of the company's earnings report for the third quarter of 2022.Johnson & Johnson's headline numbers showed modest performance. Total revenue of $21.35 billion was up almost 7% year over year, and while net income was flat at $4.31 billion, a decline in the ...News of a legal defeat drove Johnson & Johnson 's ( JNJ 1.11%) share price down on the first trading day of the week. The ruling from a federal appeals court not only went against the company, it ...Roku and Zoom now make up 7.2% and 7.9% of the fund, respectively, though the company’s shares are each down by more than 55% year-to-date, contributing to the tech-focused fund’s subpar 2022 ...Losing out on $1.5 million annually. First, it's important to note that Buffett surely appreciated J&J's dividend payments, but losing the $1.5 million annually they represent …Apr 25, 2023 · Johnson & Johnson (JNJ 1.68%) is one of the top healthcare companies in the world. But the company's legal problems, particularly with its talc products, weighed down its financials over the past ... Johnson & Johnson Common Stock (JNJ) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Its four-year average dividend yield is 2.60%, and its forward annual dividend of $4.52 per share translates to a 2.95% yield. It paid a quarterly dividend of $1.13 per share on March 7, 2023. In terms of trailing-12-month gross profit margin, JNJ’s 67.36% is 21.4% higher than the 55.48% industry average.Aug 28, 2014 3:49 PM EDT. NEW YORK ( TheStreet) -- Johnson & Johnson ( JNJ) - shares are falling, down -0.3% to $102.89, after the company recalled certain lots of its jaw implants used to ...Its four-year average dividend yield is 2.60%, and its forward annual dividend of $4.52 per share translates to a 2.95% yield. It paid a quarterly dividend of $1.13 per share on March 7, 2023. In terms of trailing-12-month gross profit margin, JNJ’s 67.36% is 21.4% higher than the 55.48% industry average.Earnings rose 10.3% from the year-ago period. Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported fourth-quarter earnings of $1.33 ...Photo: Mark Kauzlarich/Bloomberg News. Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a ...Shares of Johnson & Johnson ( JNJ 0.15%) were sinking 4.2% lower as of 11:04 a.m. ET on Monday. The decline came after a U.S. judge ruled against the healthcare giant on Friday. Judge Michael...Why Is Johnson & Johnson (JNJ) Stock Down Today? Jan 30, 202311:57 PST It’s a sea of red in the stock market today, but some companies are clearly under …A New Jersey bankruptcy judge threw out the second chapter 11 case that Johnson & Johnson filed to resolve its mass talc liabilities, again shutting down the healthcare-product company’s plan to ...Oct 18, 2022 · Johnson & Johnson (NYSE: JNJ) stock is on the move Tuesday following the release of the company’s earnings report for the third quarter of 2022. The JNJ earnings report starts with adjusted ... Apr 19, 2023 · Shares of Johnson & Johnson dipped nearly 3% on Tuesday after the company released first-quarter results. J&J posted a loss of $68 million, or 3 cents a share, as earnings were largely wiped out ... J&J’s consumer health spinoff Kenvue begins trading at $25.53 per share. Shares of Johnson & Johnson ’s consumer-health spinoff Kenvue jumped 22% Thursday after its market debut on the New ...If you experience any issues with this process, please contact us for further assistance. ... current information made available by Johnson & Johnson Services, ...Fahner said Johnson & Johnson’s chairman, James E. Burke, called him during the early days of the investigation and asked how he could help. Fahner recalled having just one request: “Pull all ...Got upgraded today. Pays a 3% dividend yield and trades at 15x forward PE ... It boils down to the talc-asbestos lawsuit, an overhang that led him to sell ...Lindsey Jacobson. Johnson & Johnson, the biggest pharmaceutical company in the U.S. based on market cap, announced in November 2021 it plans to spin off its consumer …Johnson & Johnson (JNJ 1.68%) is one of the top healthcare companies in the world. But the company's legal problems, particularly with its talc products, weighed down its financials over the past ...Photo: Mark Kauzlarich/Bloomberg News. Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a ...Johnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by London Co. of Virginia marketbeat.com - December 1 at 12:35 PM: Johnson & Johnson (NYSE:JNJ) …Drugmaker Johnson & Johnson has halted production of its single-dose COVID-19 vaccine, according to a New York Times report. The pharmaceutical company last year quietly shut down production at a ...21-yan, 2014 ... Johnson & Johnson (JNJ) falls after the company announced that it expects full-year 2014 earnings to come in short of forecasts.10-yan, 2022 ... Johnson & Johnson, the biggest pharmaceutical company in the U.S. based ... Best Mortgages for Small Down Payment · Best Mortgages for No Down ...Find the latest Protagonist Therapeutics, Inc. (PTGX) stock quote, history, news and other vital information to help you with your stock trading and investing.Two prominent U.S. coronavirus stocks ended the week on a down note. Pfizer ( PFE 0.07%) and Johnson & Johnson ( JNJ -0.20%) both fell on the day by nearly 3%. This followed a prominent investment ...Jul 21, 2023 · The blue chip index was helped by IBM and Johnson & Johnson. The S&P 500 and Nasdaq were dragged down by Netflix and Tesla, which dropped after earnings reports. Here’s what else to know today: Jun 4, 2014 · Johnson & Johnson (NYSE:JNJ) has been hitting 52 week highs, seemingly every day. I would argue that the performance of the stock has been a result of some dynamic growth in both revenues and ... Why is jnj down today

Right now, analysts are expecting 2023 S&P 500 EPS to be $225 per share followed by $250 EPS in 2024, which is a robust 11.1% year over year growth rate. …. Why is jnj down today

why is jnj down today

Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating two publicly traded ...What happened. Shares of drugmaker AbbVie ( ABBV -2.81%) are off by 7.8% in Wednesday afternoon's trading session following a decision from the Food and Drug Administration to require a heart-risk ...Dec 1, 2023 · If a stock's EPS consensus estimate is $1.10 now vs. $1.00 the week before, that will be reflected as a 10% change. If, on the other hand, it went from $1.00 to 90 cents, that would be a -10% ... Jan 30, 2023 · One such notable decliner today is Johnson & Johnson (NYSE: JNJ ), with shares of JNJ stock dropping 4% in early afternoon trading. This decline is notable because JNJ stock doesn’t tend to see ... Johnson & Johnson -- now a slimmed-down and more focused healthcare company following the spinoff of its consumer-products business as Kenvue -- handily …What happened. Shares of Johnson & Johnson (JNJ 0.73%) climbed higher this morning and are trading up 2.2% as of 11 a.m. ET.. The healthcare giant received a thumbs-up from an analyst, who sees ...Johnson & Johnson is to stop selling and making talc-based baby powder globally, two years after it ended sales in the US and Canada. The healthcare firm has faced tens of thousands of lawsuits ...Johnson & Johnson. Market Cap. Today's Change. Current Price. $147.66. Price as of November 14, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley ...Jan 30, 2023 · News of a legal defeat drove Johnson & Johnson 's ( JNJ 1.11%) share price down on the first trading day of the week. The ruling from a federal appeals court not only went against the company, it ... Johnson & Johnson is now emerging from under a cloud of litigation. Earlier this year, the company agreed to pay $5 billion to settle claims it contributed to the opioid crisis in the U.S. Drug ... marketbeat.com - November 27 at 8:45 AM. NVIDIA Co. (NASDAQ:NVDA) Shares Purchased by Guggenheim Capital LLC. marketbeat.com - November 27 at 8:39 AM. Nvidia's Blowout Quarterly Results Imply NVDA Stock Could Be Worth Over $700 Per Share. msn.com - November 26 at 5:48 PM.Get the latest Johnson & Johnson (JNJ) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.Sep 22, 2022 · Shares of Johnson & Johnson ( JNJ -0.20%) defied the overall market downturn on Thursday, with its shares rising 1.7% higher as of the market close. The big company didn't make any announcements ... Got upgraded today. Pays a 3% dividend yield and trades at 15x forward PE ... It boils down to the talc-asbestos lawsuit, an overhang that led him to sell ...The Dow Jones Industrial Average fell 388 points, or 1.1%, its biggest one-day decline since March. The Nasdaq Composite lost 1.6%. The S&P 500 is now below the threshold that it passed to enter ...18-okt, 2022 ... Johnson & Johnson (JNJ) stock is on the move Tuesday following the release of the company's earnings report for the third quarter of 2022.Johnson & Johnson's vaccine is a single-dose adenovirus-based vaccine. It is a viral vector vaccine that uses a weakened live pathogen (adenovirus) as the delivery method (vector) for transporting a recombinant vaccine for COVID-19. The vaccine is also sometimes referred to as Ad26.COV2.S. Recombinant vaccines use a small piece of …Nvidia stock was down 4.9% to $438.60. It was on pace for its largest percent decrease since May 31, when it fell 5.68%, according to Dow Jones Market Data. Nvidia shares have soared 200% in 2023 ...For the upcoming trading day on Monday, 4th we expect Johnson & Johnson to open at $157.44, and during the day (based on 14 day Average True Range), to move between $156.28 and $160.48, which gives a possible trading interval of +/-$2.10 (+/-1.32%) up or down from last closing price. If Johnson & Johnson takes out the full …To add symbols: Type a symbol or company name. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return./ Today's Market / Why Is Johnson & Johnson (JNJ) Stock Down Today? Q3 beats are being overshadowed by the company's full-year guidance By William …Earnings rose 10.3% from the year-ago period. Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported fourth-quarter earnings of $1.33 ...Roku and Zoom now make up 7.2% and 7.9% of the fund, respectively, though the company’s shares are each down by more than 55% year-to-date, contributing to the tech-focused fund’s subpar 2022 ...Sales of JNJ's COVID vaccine were $747m in Q123, up from $457m in the prior year, but the vaccine may not generate any revenues at all in Q223, which will drag down the division's performance.Analysts are looking for net income of $2.51 per share on revenue of $21 billion. The company regularly beats estimates, but just by single digits. So far, the only thing the new JNJ has done ...Jan 30, 2023 · One such notable decliner today is Johnson & Johnson (NYSE:JNJ), with shares of JNJ stock dropping 4% in early afternoon trading. This decline is notable because JNJ stock doesn’t tend to see such large single-day moves. The company’s decline today appears to be tied to reports that a U.S. court has rejected Johnson & Johnson’s strategic ... Shares of Johnson & Johnson ( JNJ -0.20%) defied the overall market downturn on Thursday, with its shares rising 1.7% higher as of the market close. The big company didn't make any announcements ...Johnson & Johnson is now emerging from under a cloud of litigation. Earlier this year, the company agreed to pay $5 billion to settle claims it contributed to the opioid crisis in the U.S. Drug ... Some economists predict that rate cuts could be in store in the second half of 2023. This could mean that the U.S. dollar will weaken somewhat later this year. If so, Johnson & Johnson's reported ...Johnson & Johnson. Market Cap. Today's Change. Current Price. $147.66. Price as of November 14, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ from The Motley ...See full list on fool.com Johnson & Johnson (JNJ 1.68%) is one of the top healthcare companies in the world. But the company's legal problems, particularly with its talc products, weighed down its financials over the past ...Get Johnson & Johnson (JNJ.N) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsIndeed, the S&P 500 and Nasdaq Composite closed down by 1.3% and 1.8% on Thursday. With today’s drop, the stock market’s recent correction has grown some threatening thorns. After climbing ...Here’s Why. Oct. 19, 2023 at 10:09 a.m. ET by Barron's Johnson & Johnson beats earnings estimates and downplays obesity drugs’ impact on its med-tech businessHistorical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades ...18-apr, 2023 ... Johnson&Johnson #youtube #yahoofinance Yahoo Finance's Anjalee Khemlani joins the Live show to discuss news that Johnson & Johnson is ...J&J raised its full-year earnings and sales view on strong third quarter results. Adjusted earnings per share in 2019 are expected in the range of $8.62 - $8.67, up from the prior range of $8.53 ...Analysts are looking for net income of $2.51 per share on revenue of $21 billion. The company regularly beats estimates, but just by single digits. So far, the only thing the new JNJ has done ...Meanwhile, TJX Companies Inc. (TJX), the owner of discount stores T.J. Maxx, HomeGoods, and Marshalls, today said revenue increased 8% over last year in the second quarter, with comparable store ...Owning Kenvue ( NYSE: KVUE ), the consumer health spin-off of Johnson & Johnson ( JNJ ), absolutely is not a poor decision. Kenvue has a diversified portfolio of brands, 10 of which generated 2022 ...View the real-time Johnson & Johnson (NYSE JNJ) share price and assess historical data, charts, technical analysis and the share chat forum.Earnings rose 10.3% from the year-ago period. Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported fourth-quarter earnings of $1.33 ...Johnson & Johnson is now emerging from under a cloud of litigation. Earlier this year, the company agreed to pay $5 billion to settle claims it contributed to the opioid crisis in the U.S. Drug ... Here’s what J&J reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $2.66 ...Photo: Mark Kauzlarich/Bloomberg News. Johnson & Johnson reported a 25% drop in earnings and declining sales for the fourth quarter as demand dropped for its Covid-19 vaccine, while providing a ...Get the LIVE share price of Johnson & Johnson(JNJ) and stock performance in one place to strengthen your trading strategy in US stocks.Shares of healthcare giant Johnson & Johnson (JNJ 0.92%) are down more than 13% this year even as the S&P 500 is up 4%. In fact, the stock is trading only a bit higher than its 52-week low ...Dec 1, 2023 · A high-level overview of Johnson & Johnson (JNJ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. . Buyalerts.com price